000739SZSE

Implementation Assessment Management Measures for the 2026 Stock Option Incentive Plan of Pro Pharmaceutical Co., Ltd.

Apeloa Pharmaceutical Co., Ltd.··4 pages

✨ AI Summary

The announcement outlines the management measures for the implementation of Pro Pharmaceutical's 2026 stock option incentive plan. The plan aims to enhance corporate governance and align employee performance with company goals. Key performance indicators include net profit growth targets ranging from 10% to 50% over four years. The assessment will involve multiple levels, including company, division, and individual performance evaluations.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Implementation Assessment Management Measures for the 2026 Stock Option Incentive Plan of Pro Pharmaceutical Co., Ltd.

To ensure the smooth implementation of Pro Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") 2026 stock option incentive plan (hereinafter referred to as "this incentive plan"), to form a well-balanced value distribution system, fully motivate employees, and ensure the realization of the company's development strategy and operational objectives, these measures are formulated in accordance with the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Management Measures for Equity Incentives of Listed Companies, and other relevant laws, regulations, normative documents, and the Articles of Association of Pro Pharmaceutical Co., Ltd., combined with the actual situation of the company.

1. Purpose of Assessment

To further improve the corporate governance structure, establish and perfect the incentive and restraint mechanism, ensure the smooth implementation of the 2026 stock option incentive plan, maximize the effectiveness of this equity incentive, and ensure the realization of the company's development strategy and operational objectives.

2. Principles of Assessment

The assessment must adhere to the principles of fairness, openness, and impartiality, strictly evaluating according to these measures and the performance of the assessment targets, thereby closely linking the equity incentive plan with the work performance and contributions of the incentive objects, improving management performance, and maximizing the interests of the company and all shareholders.

3. Scope of Assessment

These measures apply to all incentive objects participating in the company's incentive plan.

4. Assessment Institutions

  1. The Board of Directors' Compensation and Assessment Committee is responsible for leading and organizing the assessment of the incentive objects.
  2. The Human Resources Department is responsible for the specific implementation of the assessment and reports to the Board of Directors' Compensation and Assessment Committee.
  3. The Human Resources Department, Finance Department, and other relevant departments are responsible for collecting and providing relevant assessment data and ensuring the authenticity and reliability of the data.
  4. The Board of Directors is responsible for the approval of these measures and the review of assessment results.

5. Performance Evaluation Indicators and Standards

(1) Company-Level Performance Assessment Requirements

  1. The initial grant of this incentive plan will use the four accounting years from 2026 to 2029 as the performance assessment years, with specific company-level performance assessment indicators as follows:

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.